1. Home
  2. HIW vs OCUL Comparison

HIW vs OCUL Comparison

Compare HIW & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HIW

Highwoods Properties Inc.

HOLD

Current Price

$27.56

Market Cap

2.9B

Sector

Real Estate

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$11.37

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIW
OCUL
Founded
1978
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.4B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
HIW
OCUL
Price
$27.56
$11.37
Analyst Decision
Hold
Strong Buy
Analyst Count
7
10
Target Price
$31.00
$22.56
AVG Volume (30 Days)
1.4M
3.1M
Earning Date
02-10-2026
11-04-2025
Dividend Yield
7.57%
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
$811,773,000.00
$55,783,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.57
$11.96
P/E Ratio
$22.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.19
$5.79
52 Week High
$32.76
$16.44

Technical Indicators

Market Signals
Indicator
HIW
OCUL
Relative Strength Index (RSI) 63.94 38.41
Support Level $25.50 $10.92
Resistance Level $26.14 $13.06
Average True Range (ATR) 0.48 0.51
MACD 0.27 -0.24
Stochastic Oscillator 100.00 17.47

Price Performance

Historical Comparison
HIW
OCUL

About HIW Highwoods Properties Inc.

Highwoods Properties Inc is a real estate investment trust engaged in the acquisition, ownership, management, and leasing of properties in urban areas throughout the Southern United States. In terms of total square footage, the vast majority of the company's real estate portfolio comprises office buildings in terms. Highwoods Properties derives nearly all of its income in the form of rental revenue from the tenants of its buildings. The majority of this revenue comes from its holdings in the urban markets of Atlanta, Raleigh, Nashville, and Tampa. These cities also account for the majority of the square footage under the company's ownership. Highwoods Properties customers include the U.S. Government, financial services firms, industrial supply retailers, and healthcare companies.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: